Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

Pharm drugs final > antimicrobials, antifungals, antivirals, cancer, immunoregulatory > Flashcards

antimicrobials, antifungals, antivirals, cancer, immunoregulatory Flashcards

1
Q

Penicillin

A

antimicrobial - beta lactam

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

cephalosporin

A

antimicrobial - beta lactam

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

carbapenem

A

antimicrobial - beta lactam - imipenem/cilastatin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

monobactam

A

antimicrobial - aztreonam only one - beta lactam

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

glycopeptide

A

antimicrobial - vancomycin, bacitracin - for topical use for gram-positive and certain gram-negative bacteria. 


How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

tetracycline

A

antimicrobial - • Drug of choice • Rickettsial diseases: Rocky Mountain spotted fever, typhus • Mycoplasma pneumoniae
• Chlamydia pneumoniae
• Lyme disease (Borrelia burgdorferi) • Brucellosis
• Alternative agent • Plague
• Pelvic inflammatory disease
• As treatment of syndromes • Acne: low-dose oral or topical

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

macrolide

A

antimicrobial - erythromycin

Drug of choice Mycoplasma pneumonia,
Streptococcal (group A streptococcus (GAS)) upper respiratory tract 
infection (penicillin-allergic patient), Legionella infection 

Alternative agent 
• Lyme disease
• Chlamydia infection 

As treatment of syndromes 
• Bacterial bronchitis
• Otitis media (middle ear infection) with sulfonamide • Acne, topical 

Prophylaxis 
• Large bowel surgery • Oral surgery

and ketolides

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

aminoglycosides

A

antimicrobial. ineffective against anaerobic bacteria and fungi

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

chloramphenicol

A

antimicrobial - aplastic anemia!!!!!!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

sulfonamides

A 
antimicrobial - sulfamethoxazole
gastrointestinal disturbances (nausea, vomiting, anorexia) and allergic skin reactions (such as rash and urticaria).
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

trimethoprim

A

antimicrobial - gastrointestinal disturbances (nausea, vomiting, anorexia) and allergic skin reactions (such as rash and urticaria).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

• Fluoroquinolones

A

antimicrobials - • The earlier generation agents are, in general, more narrow spectrum than the later ones.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

nitrofurans

A

antimicrobials - • Not to be used in patients with a creatinine clearance of 60 ml/min or less

urinary tract infection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

colistin (polymixin E), polymixin B

A

antimicrobials • Their use was abandoned, except in patients with cystic fibrosis, because of toxicity (they react with and affect the membranes of human cells, resulting in kidney damage and neurotoxicity).

• Because they are not well absorbed from the gastrointestinal tract, oral administration is occasionally used for the treatment of diarrhea.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

rifampin

A

antimicrobials - anti-tuberculosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

isonazid

A

antimicrobials - anti-tuberculosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

pyrazinamide

A

antimicrobials - anti-tuberculosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

• rifampin, dapsone, clofazimine

A

antimicrobials - anti-leprosy

    1. Is presumed that rifampin acts by inhibition of Mycobacterium leprae DNA-dependent RNA polymerase.
    1. Similar to sulfonamides, dapsone (diamino-diphenyl sulphone) acts as an inhibitor of dihydropteroate synthetase in folate synthesis to produce a bacteriostatic effect.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

flucytosine

A

antifungals - nucelic acid synthesis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

caspofungin

A

antifungals - cell wall

o blocks the synthesis of a major fungal cell wall component, 1-3-beta-D-glucan.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

griseofulvin

A

antifungals - nuclear division - o inhibits fungal mitosis through interaction with 
polymerized microtubules 


How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

amphotericin B

A

antifungals - cell membrane - o Polyenes act by binding to sterols in the cell membrane and forming channels, allowing K+ and Mg2+ to leak out.

o Fungi that not have ergosterol are not susceptible to amphotericin B.
o The initial reactions, usually fever to as high as 40° C, chills, headache, general discomfort, nausea, and occasionally hypotension. 

o Anemia with hematocrits of 22% to 35% develops in most patients who receive a normal course of therapy. This is the result of reduced erythropoiesis due to inhibition of erythropoietin production. 


How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

nystatyn

A

antifungals - ergosterol component

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

fluconazole

A

antifungals - CYTOCHROME P450!!!!!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

itraconazole

A

antifungals - CYTOCHROME P450

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

terbinafine

A

o Terbinafine inhibits ergosterol biosynthesis 
via inhibition of squalene epoxidase 


How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

antimetabolites (S phase)

A

cancer - cell cycle - growth fraction malignancies (high replicating cells), such as hematologic cancers. 


How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

taxanes

A

cancer - cell cycle - growth fraction malignancies (high replicating cells), such as hematologic cancers. 


How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

vinca alkaloids (M phase)

A

cancer - cell cycle - growth fraction malignancies (high replicating cells), such as hematologic cancers. 


How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

antitumor antibiotics (G2-M phase)

A

cancer - cell cycle - growth fraction malignancies (high replicating cells), such as hematologic cancers. 


How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

alkylating agents

A

cancer - Cell-cycle nonspecific (CCNS) drugs (useful against tumors that have a low percentage of replicating cells, also effective against replicating cells).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

anthracyclines

A

cancer - Cell-cycle nonspecific (CCNS) drugs (useful against tumors that have a low percentage of replicating cells, also effective against replicating cells).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

antitumor antibiotics

A

cancer - Cell-cycle nonspecific (CCNS) drugs (useful against tumors that have a low percentage of replicating cells, also effective against replicating cells).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

platinum analogs

A

cancer - Cell-cycle nonspecific (CCNS) drugs (useful against tumors that have a low percentage of replicating cells, also effective against replicating cells).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

antimetabolites (methotrexate, • 6-MP and 6-TG , • 5-FU (5-Fluorouracil) and Cytarabine )

A

cancer - antineoplastic drugs - antimetabolites

o Low dose of MTX is anti-inflammatory and immuno-suppressive.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

antibiotics (• Doxorubicin and daunorubicin)

A

cancer - antineoplastic drugs

o Used in drug combinations, doxorubicin is one of the most important and widely used anticancer drugs.
o Cardiotoxicity or heart failure. 


How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

antibiotics (dactinomycin)

A

cancer - atineoplastic o This drug is also immunosuppressive.



How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

antibiotics (bleomycin)

A

cancer - antineoplastic

pulmonary toxicity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

topoisomerase inhibitors

A

cancer - antineoplastic - Topoisomerase inhibitors (Epipodophyllotoxins) (inhibit topoisomerase II- mediated religation of DNA breaks): Etoposide (VP-16), teniposide (VM-26). 

• Etoposide (VP-16) is phase-specific (active in G2).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

alkylating agents (mechlorethamine)

A

cancer - antineoplastic - • They are mutagenic and carcinogenic and can lead to a second malignancy, such as acute leukemia. 

• Mechlorethamine
o It causes lymphocytopenia. 

o It alkylates the N-7nitrogenof a guanine residue in one or both strands of a DNA molecule, leading to cross- linkage between guanine residues in the DNA chains. 


How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

alkylating agents (cyclophosphamide)

A

cancer - antineoplastic - o It is the most commonly used alkylating agent. 


How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

alkylating agents (temozolomide)

A

cancer - antineoplastic - can also cross blood-brain barrier

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
43
Q

alkylating agents (nitrosoureas)

A

cancer - antineoplastic - another group of drugs that can cross blood-brain barrier and are used to treat brain cancers. 


44
Q

alkylating agents (cisplatin and carboplatin)

A

cancer - antineoplastic - can cross-link DNA

45
Q

microtubule inhibitors (• Vincristine (VX, oncovin), vinblastine (VBL) and vinorelbine (VRB) )

A

cancer - antineoplastic - o They block cell mitosis in metaphase, are cell-cycle specific and phase-specific. 


46
Q

microtubule inhibitors (• Taxanes: paclitaxel (taxol) and docetaxel)

A

cancer - antineoplastic

47
Q

steroid hormones and their antagonists (tamoxifen)

A

cancer - antineoplastic - • For example, anti-estrogen tamoxifen is used to prevent estrogen stimulation of breast cancer cells. 

• Tamoxifen and similar drugs
• Tamoxifen is an estrogen antagonist. 

• It binds to estrogen receptor but fails to induce estrogen-responsive genes, and RNA synthesis does not ensue. The growth-promoting effects of estrogen and other factors are suppressed. 


48
Q

steroid hormones and their antagonists (toremifene)

A

cancer - antineoplastic - similar and closely related to tamoxifen 


49
Q

steroid hormones and their antagonists (fulvestrant)

A

cancer - antineoplastic - destroys estrogen receptors

50
Q

steroid homrones and their antagonists (prednisone)

A

cancer - antineoplastic - o Is a potent, synthetic, anti-inflammatory corticosteroid with less mineralocorticoid activity than cortisol. 

o For treatment of lymphoma and acute lymphocytic leukemia. 

o Binds to intracellular receptors and triggers production of specific proteins. 


Corticosteroids
• Among these drugs, prednisone is most widely used. 

• Actions and mechanisms: 
- Regression of lymphoid tissues. 
- Enhance destruction of lymphocytes (especially T lymphocytes). 
- Interfere with the cell cycle of activated lymphoid cells. 
- Inhibit leukocyte and other cell functions (leukocyte recruitment, adhesion, migration, chemotaxis, phagocytosis, activation of CTLs, functions of endothelial cells, fibroblasts, etc.). 
- Inhibit antibody formation due to the drug’s catabolic effect. 
- Inhibit inflammatory mediators (eg, kinins, prostagladins, leukotriences, IL-1 and IL-6, etc.).

51
Q

monoclonal antibodies (trastuzumab, cetuximab)

A

cancer - antineoplastic - They are employed as an informer,identifying malignant cells as targets for attack by complement-dependent cytotoxicity (CDC) and antibody-dependent cell-mediated cytotoxicity (ADCC). 

They are also used to block selected growth factor receptors to affect cell growth.
They are also used as biological “missiles” for carrying a radio-pharmaceutical or biologic toxin warhead to the targeted cancer cells.

Trastuzumab
Causes regression of breast cancer. 

• Cetuximab
o used in combination for the 1st-line therapy of metastatic colorectal cancer, head and neck cancer.

52
Q

biological response modifiers (interleukin 2)

A

cancer - antineoplastic - (interfere signal transduction pathways): e.g., IFN-

53
Q

tyrosine kinase inhibitors (imatinib, gefinitib)

A

cancer - antineoplastic - Imatinib and gefitinib, are both oral drugs.
• Imatinib acts as a signal transduction inhibitor, is used specifically to inhibit the activity of tumor tyrosine kinase BCR-ABL, hence to inhibit cell proliferation, for very effective treatment of chronic myelogenous leukemia. Mutations in the BCR-ABL kinase domain occur that lead to resistance. (Similar drugs: dasatinib and nilotinib, more potent)
• Gefitinib is a specific inhibitor of the EGFR tyrosine kinase that competitively inhibits ATP binding. But it has a low response rate. Similar drug: erlotinib.

54
Q

proteosome inhibitors (bortezomib)

A

cancer - antineoplastic - Bortezomib (Velcade): inhibit proteosome and permit activation of programmed cell death in neoplastic cells, for the treatment of multiple myeloma and mantle cell lymphoma.

55
Q

angiogenesis inhibitors (bevacizumab)

A

cancer - antineoplastic - The best studied proangiogenic factor is VEGF whose elevated levels are associated with poor prognosis and increased risk of metastasis in a variety of malignancies. VEGFR-1 and -2 are expressed in endothelial cells and cancer cells.

(anti-VEGF) inhibits VEGF-A.

56
Q

angiogenesis inhibitors (Vandetanib)

A

cancer - antineoplastic - is a kinase inhibitor mainly for 
VEGFR. 


57
Q

angiogenesis inhibtiors (thalidomide and lenalidomide)

A

cancer - antineoplastic - inhibit TNF

58
Q

differentiating agents - (all-trans-retinoic acid)

A

cancer - antineoplastic - All-trans-retinoic acid (ATRA, Tretinoin): drives leukemic promyelocytes

59
Q

neuramidase inhibitors (oseltamivir)

A

antiviral - • an orally active prodrug, hydrolyzed by the liver to its active form. • • GI discomfort and nausea

60
Q

neuramidase inhibitors (zanamivir)

A

antiviral - • is either inhaled or administered intranasally. Intravenous zanamivir is also available. • • Avoided in individuals with severe respiratory diseases or asthma.

61
Q

neuramidase inhibitors (peramivir)

A

antiviral agents - • a new neuraminidase inhibitor (intravenous only), approved in Dec 2014.
• • Adverse effect: serious skin reactions.

62
Q

viral uncoating inhibitors (adamantane derivatines)

A

antiviral agents - • amantadine (Symmetrel) and
o minor neurologic symptoms include insomnia, dizziness and ataxia.
o • Use with caution in patients with psychiatric, neurologic and renal problems.
• rimantadine (Flumadine).
o Both were reported to be effective for prophylaxis and treatment of susceptible strains of influenza A.
o is equally effective, does not cross blood-brain barrier (less adverse effects).
o • Both drugs can cause GI intolerance.
• These drugs are not currently recommended for prophylaxis or treatment of influenza.

63
Q

ribavirin

A

antiviral - • Oral ribavirin: for treating severe RSV infections in infants and young children.
• • Oral ribavirin: for treating chronic HCV infection (combined with injected pegIFN--2a or pegIFN--2b).
• • Intravenous and/or aerosol ribavirin: for severe influenza virus infection and for immunosuppressed patients with adenovirus, vaccinia, parainfluenza or

64
Q

hepatic viral infections (adefovir)

A

antiviral agents - o a nucleotide, also for HIV infections.

65
Q

hepatic viral infections (entecavir)

A

antiviral agents - a guanosine analog

66
Q

hepatic viral infections (telbivudine)

A

a synthetic thymidine analog

67
Q

hepatic viral infections (tenofovir)

A

antiviral agents - a nucleotide analog; also for HIV infections

68
Q

hepatic viral infections (interferon)

A

antiviral agents - • Induction of host cell enzymes that inhibit viral RNA translation, degradation of viral RNA, and stimulation of immune system.
• Adverse effects: flu-like symptoms, bone marrow suppression, neurotoxicity, autoimmune disorders

69
Q

hepatic viral infections (lamivudine)

A
  • Inhibits both HBV DNA polymerase and HIV reverse transcriptase.
  • Absorbed orally, well tolerated.
  • • For treatment of HBV and HIV infections.
70
Q

herpesvirus infections (acyclovir), • The drugs are effective only during acute phase of infections, cannot prevent recurrences.

A

antiviral - o Is the drug of choice in treating HSV1, HSV2, and VZV.
o Most common use is for treatment of genital herpes infections.
o Adverse effects depend on the routes: local irritation (topical); headache and GI upsets (oral); transient renal dysfunction at high dose (iv).

71
Q

herpesvirus infections (valacyclovir, famciclovir, penciclovir), • The drugs are effective only during acute phase of infections, cannot prevent recurrences.

A

antiviral - o Mainly used for genital herpes and VZV

o Penciclovir is only for topical use

72
Q

herpesvirus infections (ganciclovir), • The drugs are effective only during acute phase of infections, cannot prevent recurrences.

A

antiviral - o For treatment of CMV retinitis in AIDS patients, and for CMV prophylaxis in transplant patients.
o • >100timesactiveagainstCMV (cytomegalovirus) than acyclovir.


73
Q

herpesvirus infections (foscarnet), • The drugs are effective only during acute phase of infections, cannot prevent recurrences.

A

antiviral - o For the treatment of CMV retinitis in immunocompromised hosts, and for acyclovir- resistant HSV and herpes zoster infections.
o • Is only for iv administration.
o Adverse effects: nephrotoxicity, anemia, nausea and fever.

74
Q

nucleoside and nucleotide reverse transcriptase inhibitors (NRTIs) (zidovudine)

A

antiviral - anti HIV agents - • Toxic to bone marrow, headaches, toxicity can be potentiated by other drugs.

75
Q

nucleoside and nucleotide reverse transcriptase inhibitors (NRTIs) (didanosine)

A

antiviral - anti HIV agents - • o May cause pancreatitis (monitoring amylase is needed), peripheral neuropathy.

76
Q

nucleoside and nucleotide reverse transcriptase inhibitors (NRTIs) (lamivudine)

A

antiviral - anti HIV agents

77
Q

Non-nucleoside reverse transcriptase inhibitors (NNRTIs) (nevirapine)

A

antiviral - anti HIV agents - only for HIV 1 infection, lack of bone marrow, lack of cross-resistance with NRTIs

o Adverse effects: rash can be severe; fatal hepatotoxicity can occur (need to monitor transaminases).
o Induces CYP3A4 of cytochrome P450 enzymes, and metabolism of a number of other drugs. (drug interactions! — It increases metabolism of oral contraceptives, ketoconazole, methadone, metronidazole, quinidine, theophylline, warfarin.)

78
Q

Non-nucleoside reverse transcriptase inhibitors (NNRTIs) (efavirenz)

A

antiviral - anti HIV agents - only for HIV 1 infection, lack of bone marrow, lack of cross-resistance with NRTIs

o Efavirenz plus 2 NRTIs remains a preferred regimen for treatment-naïve patients.
o ATRIPLA: efavirenz + tenofovir + emtricitabine (once daily co-formulation single pill).
o Etravirine: is used when HIV-1 is resistant to other NNRTIs.

79
Q

protease inhibitors

A

antiviral - • Are selective, reversible inhibitors of HIV aspartyl protease (for formation of reverse transcriptase, protease, integrase and structural proteins), and block viral maturation.
• Potential dangerous interactions: – Excessive sedation from midazolam,
• triazolam
– Bleeding from warfarin
– Respiratory depression from fetanyl
• GI intolerance. 

• Disturbances in glucose and lipid metabolism (diabetes, hypertriacylglycerolemia, hypercholesterolemia, and fat redistribution: “buffalo hump”, and breast enlargement.).
• Ritonavir
• Saquinavir
• Lopinavir
• Indinavir and other PIs
• Well absorbed orally.
• • GI symptoms and headache.
• • Nephrolithiasis( kidneystone) mayoccur (It is not widely prescribed now).

80
Q

Viral entry inhibitors

A

antiviral - • Enfuvirtide
o Can be combined with other antiviral agents.
o – Is costly and is only given subcutaneously (twice daily).
• Maraviroc

81
Q

Integrase inhibitors (raltegravir)

A 
antiviral - •	Raltegravir (Isentress), the first in a new class of oral HIV drugs called HIV-1 integrase strand transfer inhibitors (InSTI), was approval for use in combination therapy for treatment– experienced adults infected with HIV-1 strains resistant to multiple anti-retroviral agents. 
•	Dolutegravir and elvitegravir: two newly approved integrase inhibitors for HIV treatment.
82
Q

glucocorticoids (prednisone, prednisolone, methylprednisolone)

A

immunoregulatory agents - immunosuppressive drugs - • Among these drugs, prednisone is most widely used. 

• Immunosuppressive actions and mechanisms: 
- Regression of lymphoid tissues. 
- Enhance destruction of lymphocytes (esp. T lymphocytes). 
- Interfere with the cell cycle of activated lymphoid cells. 
- Inhibit leukocyte functions (leukocyte recruitment, migration, chemotaxis, phagocytosis, activation of CTLs, etc.). 
- Inhibit antibody formation due to the drug’s catabolic effect. 
- Inhibit inflammatory mediators (eg, kinins, prostaglandins, leukotrienes, IL-1 and IL-6, etc.). 

• Prednisone and other glucocorticoids inhibit the action of COX-2 and the formation of prostaglandins by:
o Repressing COX-2 gene and enzyme expression; 

o repressing the expression of cytokines that activate COX-2; 

o blocking the function of phospholipase A2 therefore limiting the availability of arachidonic acids (the COX-2 substrates).
Clinical Uses:
• Organ and tissue transplantation.
• Auto-immune diseases: prednisone is the drug of choice in treating various autoimmune diseases. 

• Inflammatory diseases: eg, allergy and bronchial asthma, rheumatoid arthritis, inflammatory bowel disease, etc. 

• Adverse effects: suppression of pituitary- adrenal axis, peptic ulcer, catabolic effects, and increased susceptibility to serious infections. 


83
Q

cytokine inhibitors (cyclosporine (CsA))

A

immunoregulatory agents - immunosuppressive - • • Cytokines are soluble, antigen-nonspecific, signaling proteins that bind to cell surface receptors on a variety of cells.
• • Cytokinesinclude:
– Interleukins (ILs).
– Interferons (IFNs).
– Tumor necrosis factors (TNFs).
– Transforming growth factors (TGFs). – Colony-stimulating factors (CSFs).
• – Chemokines.

• IL-2 is a cytokine that stimulates the proliferation of antigen-primed (helper) T cells, which subsequently produce more IL-2, IFN-

84
Q

cytokine inhibitors (tacrolimus)

A

immunoregulatory agents - immunosuppressive - • • Cytokines are soluble, antigen-nonspecific, signaling proteins that bind to cell surface receptors on a variety of cells.
• • Cytokinesinclude:
– Interleukins (ILs).
– Interferons (IFNs).
– Tumor necrosis factors (TNFs).
– Transforming growth factors (TGFs). – Colony-stimulating factors (CSFs).
• – Chemokines.

Tacrolimus is more potent and allows lower dose of glucocorticoid to be used.
• Tacrolimus binds to a different immunophilin (FKBP-12).

85
Q

cytokine inhibitors (sirolimus)

A

immunoregulatory agents - immunosuppressive - • • Cytokines are soluble, antigen-nonspecific, signaling proteins that bind to cell surface receptors on a variety of cells.
• • Cytokinesinclude:
– Interleukins (ILs).
– Interferons (IFNs).
– Tumor necrosis factors (TNFs).
– Transforming growth factors (TGFs). – Colony-stimulating factors (CSFs).
• – Chemokines.

o	Sirolimus (rapamycin): also binds to FKBP-12, then forming a complex with mTOR (mammalian Target Of Rapamycin). 

o	Sirolimus binding to mTOR blocks the progression of activated T cells from the G1 to the S phase of cell cycle, consequently, the proliferation of these cells. (Sirolimus does not owe its effect to lowering IL-2 production but rather, to inhibiting the cellular response to IL-2.) 

86
Q

cytotoxic drugs (azathioprine)

A

immunoregulatory agents - immunosuppressive - Antimetabolites: methotrexate (MTX), leflunomide, 
azathioprine, mycophenolate mofetil (MMF).
• Immunosuppressive antimetabolites
Are generally used in combination with glucocorticoids and calcineurin inhibitors CsA and tacrolimus. 


Azathioprine is metabolized in vivo to 6- mercaptopurine (6-MP) and then thioinosinic acid to have antitumor and immuno- suppressive effects. 


87
Q

cytotoxic drugs (mycophenolate mofetil)

A

immunoregulatory agents - immunosuppressive - Antimetabolites: methotrexate (MTX), leflunomide, 
azathioprine, mycophenolate mofetil (MMF).
• Immunosuppressive antimetabolites
Are generally used in combination with glucocorticoids and calcineurin inhibitors CsA and tacrolimus. 


(MMF) inhibits T and B lymphocyte proliferation through inhibition of purine synthesis (therefore inhibits the generation of CTLs and plasma cells). 


88
Q

cytotoxic drugs (alkylating agents: cyclophosphamide)

A

immunoregulatory agents - immunosuppressive

89
Q

cytotoxic drugs (antimetabolites: methotrexate)

A

immunoregulatory agents - immunosuppressive - Is the mainstay of disease- modifying anti-rheumatic drugs. Doses are much lower than those needed in cancer chemotherapy. 

MTX is structurally related to folic acid, and acts as an antagonist of that vitamin by inhibiting dihydrofolate reductase – the enzyme that converts folic acid to its active coenzyme form: tetrahydrofolic acid (FH4). 

It decreases biosynthesis of adenine, guanine, thymidine, methionine and serine, leads to depressed DNA, RNA and protein synthesis and ultimately cell death. 


90
Q

cytotoxic drugs (antimetabolites: leflunomide)

A

immunoregulatory agents - immunosuppressive - o Leflunomide reversibly inhibits dihydroorotate dehydrogenase (DHODH), and therefore deprives the cells of the precursor for uridine monophosphate. 

o It reduces pain and inflammation associated with the disease, slows the progression of structural damage. 


91
Q

immunosuppressive alkylating agents

A

immunoregulatory agents - immunosuppressive - Alkylation of DNA (covalent binding) is the cytotoxic reaction that is lethal to the cells. 

They do not discriminate between cycling and resting cells (cell-cycle nonspecific). 

They are mutagenic and carcinogenic and can lead to a second malignancy, such as acute leukemia. 


92
Q

antibodies and biological agents (antithymocyte globulins)

A

immunoregulatory agents - immunosuppressive - purified polyclonal Abs (

93
Q

antibodies and biological agents (muromonab)

A

immunoregulatory agents - immunosuppressive - murine mAbs, for the depletion of human T cells. Used in autoimmune disorders and renal, cardiac and hepatic transplant patients, and depletion of T cells from the donor bone marrow. 


• Adverse effects: “cytokine release syndrome” (cytokine storm: release of TNF

94
Q

antibodies and biological agents (intravenous immunoglobulins (IVIg))

A

immunoregulatory agents - immunostimulatory - ): the IV use of polyclonal human Ig (usually prepared as IgG) pooled from thousands of healthy human donors, for treatment of Ig deficiencies, AIDS, autoimmune disorders, and bone marrow transplants.

95
Q

antibodies and biological agents (hyperimmune immunoglobulins)

A

immunoregulatory agents - immunostimulatory - IV Ig with high titers of Abs against particular agents of interest such as viruses or toxins. Various hyperimmune IVIgs are available for respiratory syncytial virus, cytomegalovirus, varicella zoster, human herpes virus 3, HBV, rabies, tetanus, and digoxin overdose.

96
Q

antibodies and biological agents (omalizumab)

A

immunoregulatory agents - immunosuppressive - anti-IgE recombinant humanized
mAb blocking the binding of IgE to Fc

97
Q

antibodies and biological agents (IL-2 receptor antagonis) (basiliximab, daclizumab)

A

immunoregulatory agents - immunosuppressive - o Are used for prophylaxis of acute organ rejection in adult patients. 


98
Q

antibodies and biological agents (anti-TNF reagent) (infliximab)

A

immunoregulatory agents - immunosuppressive - , is a chimeric humanized anti-TNF

99
Q

antibodies and biological agents (LFA-1 inhibition (efalizumab))

A

immunoregulatory agents - immunosuppressive - efalizumab, is a humanized IgG1 mAb against LFA-1 (lymphocyte function associated antigen- 1), blocks LFA-1

100
Q

antibodies and biological agents (TNF alpha antagonists (TNF alpha blockers))(infliximab, adalimumab, etanercept)

A

Infliximab:
• – chimeric and humanized antibody (Ab)
• Adalimumab:
• – Humanized Ab
• Etanercept:
• – fusion protein comprising part of TNF p75 receptor and the Fc portion of human IgG. It binds to TNF

101
Q

Anakinra

A
  • IsarecombinantformofIL-1receptorantagonist (IL-1Ra), which differs from the natural protein by a single methionine residue at its amino terminus. 

  • Clinicalusesandadverseeffects:similartothe TNF
102
Q

Interferon (alpha-2 beta)

A

immunoregulatory agents - immunostimulatory - • Clinical uses: to treat infections, immunodeficiency, and cancer. 

• Recombinant cytokines: IFNs, IL-2, CSFs. 

• Vaccines (active immunization). 

• Immune globulins (passive immunization). 

Interferons (IFNs)
• Bind to cell surface receptors that initiate a series of intracellular events: induction of certain enzymes, inhibition of cell proliferation, and enhancement of immune activities, including increase phagocytosis by macrophages and augmentation of specific cytotoxicity by T lymphocytes.

for treatment of tumors, AIDS, and chronic hepatitis B infections.

103
Q

Interferon (alpha - 1beta)

A

immunoregulatory agents - immunostimulatory - • Clinical uses: to treat infections, immunodeficiency, and cancer. 

• Recombinant cytokines: IFNs, IL-2, CSFs. 

• Vaccines (active immunization). 

• Immune globulins (passive immunization). 

Interferons (IFNs)
• Bind to cell surface receptors that initiate a series of intracellular events: induction of certain enzymes, inhibition of cell proliferation, and enhancement of immune activities, including increase phagocytosis by macrophages and augmentation of specific cytotoxicity by T lymphocytes.

for treatment of chronic granulomatous disease to activate phagocytes and induce their generation of oxygen metabolites. 


104
Q

interferon - 1a and interon alpha - 1beta

A

areapprovedforthe treatment of relapsing multiple sclerosis.
These last two are both immunomudulatory and immunosuppressive

105
Q

interleukin - 2 (IL-2)

A

immunoregulatory agents - immunostimulatory - Its in vivo actions:
• - Enhancement of cellular immunity (IL-2 promotes proliferation and differentiation of lymphocytes into CTLs and activation of NK cells). 


  • Lymphocytosis, eosinophilia, and thrombocytopenia. 

    • - Release of multiple cytokines (e.g., TNF, IL-1 and IFN-
106
Q

Colony stimulating factors (CSFs)

A

immunoregulatory agents - immunostimulatory agents - • Granulocyte-CSF (G-CSF) stimulates the production of neutrophils. 

• Granulocyte-macrophage CSF (GM- CSF) stimulates production of granulocytes, platelets, erythrocytes, eosinophils and macrophages.

Pharm drugs final (3 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions